Javascript must be enabled to continue!
Does Apolipoprotein E polymorphism play a role in familial Alzheimer’s Dementia
View through CrossRef
AbstractBackgroundApo E4 is the best studied genetic risk factor for sporadic Alzheimer’s disease. Apo E2 homozygosity is associated with a lower risk of Alzheimer’s disease. While rare and common variants in genes encoding APP metabolism are strongly linked to familial dementia, however family history and ApoE 4 genetic risks have been found to co‐occur.Aim to evaluate the frequency of Apo E polymorphisms and their relationship with the of family history and clinical characteristics in a cohort of 483 patients with Alzheimer’s dementia.MethodPersons with Alzheimer’s dementia were identified from a tertiary care center in India. Their family history status, and detailed clinical characteristics were collected. Genotyping was done at the apolipoprotein E (Apo E) locus using real time PCR.ResultOf the 483 patients analyzed; 142 patients had a family history of Alzheimer’s dementia in at least one first degree relative. Absence of Apo E2 homozygosity was noted in the sample. Patients with family history had a higher likelihood of an Apo E4 carrier status (OR = 1.6071; Confidence Interval 1.0840 to 2.3829 p = 0.00182).The Apo E4 frequency in the overall sample was 25.05%.ConclusionThere is a correlation between Apo E4 carrier status and the likelihood of a positive family history. It remains to be known whether family history effects are separable from Apo E4 related effects.
Title: Does Apolipoprotein E polymorphism play a role in familial Alzheimer’s Dementia
Description:
AbstractBackgroundApo E4 is the best studied genetic risk factor for sporadic Alzheimer’s disease.
Apo E2 homozygosity is associated with a lower risk of Alzheimer’s disease.
While rare and common variants in genes encoding APP metabolism are strongly linked to familial dementia, however family history and ApoE 4 genetic risks have been found to co‐occur.
Aim to evaluate the frequency of Apo E polymorphisms and their relationship with the of family history and clinical characteristics in a cohort of 483 patients with Alzheimer’s dementia.
MethodPersons with Alzheimer’s dementia were identified from a tertiary care center in India.
Their family history status, and detailed clinical characteristics were collected.
Genotyping was done at the apolipoprotein E (Apo E) locus using real time PCR.
ResultOf the 483 patients analyzed; 142 patients had a family history of Alzheimer’s dementia in at least one first degree relative.
Absence of Apo E2 homozygosity was noted in the sample.
Patients with family history had a higher likelihood of an Apo E4 carrier status (OR = 1.
6071; Confidence Interval 1.
0840 to 2.
3829 p = 0.
00182).
The Apo E4 frequency in the overall sample was 25.
05%.
ConclusionThere is a correlation between Apo E4 carrier status and the likelihood of a positive family history.
It remains to be known whether family history effects are separable from Apo E4 related effects.
Related Results
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
AbstractBackgroundApathy, characterized by decreased interest, initiative, and emotional reactivity, is amongst the most common neuropsychiatric symptoms in dementia. However, apat...
Analysis of SMOC2 gene variants in familial and non-familial primary open angle glaucoma Pakistani patients
Analysis of SMOC2 gene variants in familial and non-familial primary open angle glaucoma Pakistani patients
AIM: To find out the association of secreted protein acidic and rich in cysteine (SPARC)-related modular calcium binding 2 (SMOC2) gene variants rs2255680 and rs13208776 with genot...
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Abstract
Pharmacotherapy of dementia is a critical intervention for managing symptoms of and slowing progression of dementia. However, evidence on prescribing patter...
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study
Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study
Abstract
Background
The independent and additive associations of walking pace and grip strength on dementia risk and the potential modifying effects...
Center for Alzheimer Research at Karolinska Institutet, Sweden
Center for Alzheimer Research at Karolinska Institutet, Sweden
AbstractCenter for Alzheimer Research (CAR) is a hub for the research in Alzheimer’s disease and other dementias conducted at Karolinska Institutet (Stockholm, Sweden). CAR started...
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Abstract
Introduction:Dementia is on the rise due to increasing proportion of old people in Sub-Saharan Africa (SSA). Although dementia is misattributed to normal ageing or...

